Skip to main content
CTKB logo

CTKB · Cytek Biosciences, Inc. · Held by Funds

Track CTKB — free
$5.89 +0.30 (+5.37%) At close · Oct 26
Market Cap
$765.60M
Shares
129.98M
Volume · Oct 26 1.24M Avg daily vol (3M) 1.13M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of CTKB by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 13.13% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 3.33% 4,325,857
Index ETFs 9.80% 12,739,956
Active ETFs 1.10% 1,423,971
Active funds 4.50% 5,848,269
Unclassified 2.77% 3,606,252
All registered funds 21.50% 27,944,305
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding CTKB

165 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 165 positions
Key facts CIK 1831915 CUSIP 23285D109 13F (30d) 19 filings 19 filers Visit website Investor relations